DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Chow LQ, Haddad R, Gupta S. et al.
Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase ib keynote-012 expansion cohort.
J Clin Oncol 2016;
34: 3838-3845
We do not assume any responsibility for the contents of the web pages of other providers.